- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 219
Daily deal net: December 8, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Dec 8, 202017EdTech secures $288m in initial public offering
The ByteDance-backed learning software and tutoring services provider priced its shares in the middle of their range as it went public in the US.
Dec 8, 2020MicroTech Medical pumps in $88m
Lilly Asia Ventures contributed to a round for the diabetes device developer that was co-led by Tencent, Beijing Taikang Investment Management and IDG Capital.
Dec 8, 2020Wizard Games conjures up Tencent investment
The online shooting game developer has secured a nine-digit yuan amount from Tencent as it prepares to launch a sequel to its most popular title.
Dec 8, 2020Cuorips curates fresh funding
Asahi Intecc, Dai-Dan, StemCell Institute and Taiko Pharmaceutical all took part in a $19.3m round for the cell-derived heart therapy developer.
Dec 7, 2020DeepExi dips into $40m
SPDB International has joined Bertelsmann Asia Investments in a series A4 round that took the digitalisation technology provider's overall funding to at least $139m.
Dec 7, 2020Bloks builds series A round
Legend Capital co-led a $50.5m round for the children's building block producer with Source Code Capital.
Dec 7, 2020Snowball gathers $120m from Orchid Asia
The private equity firm has supplied series E funding for the financial data provider, adding to earlier cash from investors including Renren and Ant Group.
Dec 7, 2020Campfire warms up with new funding
Base and Marui Group were among the investors in the crowdfunding service's $28.8m series E round which, together with its series D, totalled $34.6m.
Dec 7, 2020Canbridge catches $43m in series E
Returning investor Tigermed helped the cancer and rare disease therapy developer close a round that will support commercialisation of its Hunter syndrome drug.
Dec 7, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


